AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE. (September 2021) - Macaluso, F.S.; Cappello, M.; Crispino, F.; Grova, M.; Privitera, A.C.; Piccillo, G.; Magnano, A.; Ferracane, C.; Belluardo, N.; Giangreco, E.; Fries, W.; Viola, A.; et al.